New Jersey Law Journal
The New Jersey Law Journal recently featured Wilentz Shareholder and Co-Chair of the Corporate, Health and Cannabis Law team, Michael Schaff, in an article stating his thoughts on the Advisory Committee on Professional Ethics' opinion regarding New Jersey Lawyers using regulated cannabis and operating/investing in a regulated cannabis business without violating the Rules of Professional Conduct.
NJ Attorneys Get the Green Light to Use and Invest in Regulated Cannabis
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.